Health Care • Biotechnology: Pharmaceutical Preparations
$78.62 ▼ -2.22
(-2.75%)
MKT CAP: $3.59B • VOL: 525.4K
52W L $40 52W H $100
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$66
MEDIAN
$88
MEAN
$90
HIGH
$107
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE IRON TAPE
IRON // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $95.13 | $90.41 | 2025-02-14 | $71.54 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $99.06 | $92.77 | 2025-02-06 | $73.90 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $89.63 | $86.48 | 2025-01-29 | $75.48 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $80.19 | — | 2025-01-17 | $77.05 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $69.19 | $74.69 | 2025-01-09 | $69.97 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $93.56 | $81.76 | 2024-12-18 | $68.40 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $76.26 | $79.41 | 2024-12-04 | $73.12 | -4.3% | 48% | C |